Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2000The Journal of Clinical Pharmacology

The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64–0796/GS4104) in Healthy Adult and Elderly Volunteers

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJoseph MassarellaJanssen (United States)GHGeorge Z. HeEstée Lauder (United States)ADAlbert DorrZoetis (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Massarella et al. (2000) studied this question.

synapsesocial.com/papers/6a87f48b4a20e1705414b355https://doi.org/10.1177/00912700022009567
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Effectiveness of Vaccination against Influenza in Healthy, Working Adults1995 · 678 citations
  2. 2Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection1998 · 255 citations
  3. 3Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 40711998 · 224 citations